Thomas S.K. Gilbert - Concepedia

Author

Thomas S.K. Gilbert

University of North Carolina at Chapel Hill ORCID

Also Known As

Frye, Stephen V, Graves, Lee M., Graves, Paul R., Herring, Laura E., Lazear, Eric, Okumu, Denis O., T. S. Karim Gilbert, T.S. Karim Gilbert, Thomas S K Gilbert, Thomas S. K. Gilbert

Publications

950

Citations

H-Index

Concepts

All Affiliations

University of North Carolina at Chapel Hill UNC Lineberger Comprehensive Cancer Center Translational Genomics Research Institute Harvard University Finland University

About

Thomas S.K. Gilbert is an author at University of North Carolina at Chapel Hill specializing in medicine, cell biology, and tumor biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	6	6	363
2	Cell Biology	5	5	343
3	Natural Sciences	2	2	221
4	Biochemistry	2	2	221
5	Biology	1	1	35

Thomas S.K. Gilbert

Publications

923

Citations

H-Index

Page 1

	Year	Citations
Mitochondrial Protease ClpP is a Target for the Anticancer Compounds ONC201 and Related Analogues Paul R. Graves, Lucas J. Aponte‐Collazo, Emily M.J. Fennell, ACS Chemical Biology	2019	195
KRAS Suppression-Induced Degradation of MYC Is Antagonized by a MEK5-ERK5 Compensatory Mechanism Angelina V. Vaseva, Devon R. Blake, Thomas S.K. Gilbert, Cancer Cell Reductive StressSignal TransductionBiochemistryNatural SciencesReceptor Tyrosine Kinase	2018	186
Low-Dose Vertical Inhibition of the RAF-MEK-ERK Cascade Causes Apoptotic Death of KRAS Mutant Cancers Irem Ozkan‐Dagliyan, J. Nathaniel Diehl, Samuel D. George, Cell Reports Kras Mutant CancersApoptosisCell DeathCancer BiologyTumor Biology	2020	97
Application of a MYC degradation screen identifies sensitivity to CDK9 inhibitors in KRAS-mutant pancreatic cancer Devon R. Blake, Angelina V. Vaseva, Richard G. Hodge, Science Signaling	2019	70
Brigatinib causes tumor shrinkage in both NF2-deficient meningioma and schwannoma through inhibition of multiple tyrosine kinases but not ALK Long‐Sheng Chang, Janet L. Oblinger, Abbi E. Smith, PLoS ONE	2021	49
EPH receptor signaling as a novel therapeutic target in NF2-deficient meningioma Steven P. Angus, Janet L. Oblinger, Timothy J. Stuhlmiller, Neuro-Oncology	2018	38
Probing the global kinome and phosphoproteome in <i>Chlamydomonas reinhardtii</i> via sequential enrichment and quantitative proteomics Emily G. Werth, Evan W. McConnell, Thomas S.K. Gilbert, The Plant Journal BiologyQuantitative ProteomicsProteomic TechnologyProkaryotic SystemBiochemistry	2016	35
Targeting p130Cas- and microtubule-dependent MYC regulation sensitizes pancreatic cancer to ERK MAPK inhibition Andrew M. Waters, Tala O. Khatib, Bjoern Papke, Cell Reports	2021	31
Kinome Profiling Identifies Druggable Targets for Novel Human Cytomegalovirus (HCMV) Antivirals Kyle C. Arend, Erik M. Lenarcic, Heather A. Vincent, Molecular & Cellular Proteomics	2017	30
Mitochondrial Matrix Protease ClpP Agonists Inhibit Cancer Stem Cell Function in Breast Cancer Cells by Disrupting Mitochondrial Homeostasis Yoshimi Endo Greer, Lídia Hernandez, Emily M.J. Fennell, Cancer Research Communications	2022	29

Page 1